衰弱、遗传风险与静脉血栓栓塞症的长期风险:基于英国生物银行研究的见解
本研究纳入英国生物银行2006至2010年招募的315 523名参与者,用身体衰弱和衰弱指数评估衰弱状态,采用Cox比例风险模型分析衰弱与静脉血栓栓塞症(VTE)长期风险的关联,并在258 461名有遗传数据的参与者中探讨衰弱与遗传风险的交互和联合效应。结果显示衰弱与VTE风险升高相关(身体衰弱:HR 1.63,95%CI 1.49-1.78;衰弱指数:HR 1.66,95%CI 1.53-1.78),高遗传风险合并衰弱者VTE风险最高(身体衰弱:HR 3.83,95%CI 3.22-4.55;衰弱指数:HR 3.96,95%CI 3.41-4.62),衰弱与遗传风险存在显著加性交互,衰弱介导了癌症与VTE关联的约14%及肥胖与VTE关联的约9%。
要点
- 衰弱与VTE长期风险升高相关:身体衰弱HR 1.63(95%CI 1.49-1.78),衰弱指数HR 1.66(95%CI 1.53-1.78)。
- 高遗传风险合并衰弱者VTE风险最高:身体衰弱HR 3.83(95%CI 3.22-4.55),衰弱指数HR 3.96(95%CI 3.41-4.62)。
- 衰弱与遗传风险存在显著加性交互,身体衰弱队列RERI为0.76,衰弱指数队列RERI为1.11。
核心结论
- 在一般人群中,衰弱与VTE长期风险升高显著相关。
- 结合衰弱与遗传风险有助于识别VTE高危人群。
- 衰弱显著介导了癌症、肥胖与VTE之间的关联。
研究设计与样本
- 研究纳入英国生物银行2006至2010年招募的315 523名参与者。
- 采用身体衰弱和衰弱指数评估招募时的衰弱状态,通过Cox比例风险模型评估衰弱与VTE长期风险的关联。
- 排除无遗传数据的参与者后,在258 461名参与者中进一步探讨衰弱与遗传风险的交互和联合效应,并进行中介分析。
主要发现
- 衰弱与VTE风险升高显著相关:身体衰弱HR 1.63(95%CI 1.49-1.78),衰弱指数HR 1.66(95%CI 1.53-1.78)。
- 高遗传风险合并衰弱者VTE风险最高:身体衰弱HR 3.83(95%CI 3.22-4.55),衰弱指数HR 3.96(95%CI 3.41-4.62)。
- 衰弱与遗传风险存在显著加性交互,身体衰弱队列RERI为0.76,衰弱指数队列RERI为1.11。
- 衰弱介导了癌症与VTE关联的约14%,以及肥胖与VTE关联的约9%。
临床怎么用
- 原文结论未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Frailty is more prevalent among venous thromboembolism (VTE) patients. However, the relationship between long-term VTE risk and frailty remained unexplored. This study included 315 523 participants recruited from UK Biobank between 2006 and 2010. Frailty status of participants at recruitment was evaluated by physical frailty and frailty index. The association between frailty and long-term risk of VTE was assessed through Cox proportional models. After excluded participants without genetic data, we further explored the interaction and joint effect between frailty and genetic risk in 258 461 participants. Mediation analyses were performed to investigate whether frailty mediates the association between cancer, obesity, and VTE. Results revealed significant associations between frailty and increased risk of VTE (physical frailty: HR, 1.63; 95% CI, 1.49-1.78; frailty index: HR, 1.66; 95% CI, 1.53-1.78). Participants with high genetic risk and frailty exhibited the highest VTE risk (physical frailty: HR, 3.83; 95% CI, 3.22-4.55; frailty index: HR, 3.96; 95% CI, 3.41-4.62). Frailty and genetic risk exhibited a significant additive interaction, with a relative excess risk due to interaction (RERI) of 0.76 in the physical frailty cohort, and a RERI of 1.11 in the frailty index cohort. Frailty mediated approximately 14% of the association between cancer and VTE, and 9% of the association between obesity and VTE. In conclusion, frailty is significantly associated with an increased long-term risk of VTE in the general population. Combining frailty and genetic risk can assist in the identification of high-risk VTE populations. Also, frailty significantly mediates the association between cancer, obesity, and VTE.
引用
- Xu J, Ren Q, Su Y, et al. Frailty, Genetic Risk, and Long-Term Risk of Venous Thromboembolism: Insight From a UK Biobank Study. Am J Hematol. 2025. PMID: 40548514. doi:10.1002/ajh.27753
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。